News

Neurosense Therapeutics said it's producing its ALS therapy PrimeC at a commercial scale as it prepares for potential ...
Columnist Dagmar Munn considers when she decided to share the news that she had ALS — and it wasn't when she felt "ready" to ...
The ALS therapy ATLX-1282 was developed with AIchemab's platform, which uses AI to identify therapeutic targets for difficult ...
The nationwide event will cost $20, with all funds benefiting Augie's Quest, which was founded to fund research and raise ALS ...
Implanting a sensor in the brain helped detect intended speech and allowed control of a computer for a man with ALS in a ...
Two things that are constantly required in life with ALS are love and patience, writes columnist. A little laughter also helps.
Spinogenix has received clearance from the U.S. Food and Drug Administration (FDA) to launch an expanded access program (EAP) for SPG302, its oral treatment for amyotrophic lateral sclerosis (ALS).
The real-world use of Radicava (edaravone), an infusion treatment approved for amyotrophic lateral sclerosis (ALS), may cause serious side effects — such as liver problems, blood clots, pain, brain ...
Fire the flare guns, turn on the ship-to-shore radio, and holler “Mayday! Mayday! Mayday!” That’s the first order of business for a ship that’s sinking. It needs attention — lots of attention. There’s ...
Prilenia Therapeutics has entered a collaboration and license agreement with Ferrer to codevelop and commercialize pridopidine, its therapy candidate for neurodegenerative diseases like amyotrophic ...